# Emergency Use Authorization of Medical Products and Related Authorities:  Guidance for Industry and Other Stakeholders - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/emergency-use-authorization-of-medical-products-and-related-authorities-guidance-for-industry-and-other-stakeholders/c12f7bd4-cf2a-49d0-99a0-3863c15e6b5e

> FDA guidance document: Emergency Use Authorization of Medical Products and Related Authorities:  Guidance for Industry and Other Stakeholders. Issue date: January 13, 2017. Get complete insights and analysis.

---

## Details

- Title: Emergency Use Authorization of Medical Products and Related Authorities:  Guidance for Industry and Other Stakeholders
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2017-01-13
- Comment Close Date: 2016-06-04
- Last Changed: 2024-08-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1025">FDA-2016-D-1025</a>

## Related Documents

- [Expedited Programs for Serious Conditions | Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/expedited-programs-for-serious-conditions-drugs-and-biologics/d49c172d-43db-4e76-a0fd-1f51de9ecff3)
- [Dear Health Care Provider Letters: Improving Communication of Important Safety Information](https://www.globalkeysolutions.net/guidances/guidance-document/dear-health-care-provider-letters-improving-communication-of-important-safety-information/a3ea6356-848d-4286-86e9-8ac6013377e1)
- [Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims](https://www.globalkeysolutions.net/guidances/guidance-document/hypertension-indication-drug-labeling-for-cardiovascular-outcome-claims/79efdd86-3643-466c-8fe3-82b6ad2e95ff)